Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.160
-0.060 (-4.92%)
At close: Apr 24, 2026, 4:00 PM EDT
1.180
+0.020 (1.72%)
After-hours: Apr 24, 2026, 7:20 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $11.78 million as of April 24, 2026. Its market cap has increased by 30.46% in one year.
Market Cap
11.78M
Enterprise Value
7.96M
1-Year Change
30.46%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $11.78M, a decrease of -97.12%. That is a compound annual growth rate of -24.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 11.78M | 30.49% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 13.00M |
| BioCardia | 12.69M |
| Cyclerion Therapeutics | 12.43M |
| Cellectar Biosciences | 11.70M |
| Chemomab Therapeutics | 11.59M |
| Reviva Pharmaceuticals Holdings | 11.53M |
| BioLineRx | 11.36M |
| BioVie | 11.31M |